Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

51 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Considerations and Guidance for the Structure, Organisation, and Operation of Cardiometabolic Prevention Units: A Consensus Statement of the Inter-American Society of Cardiology.
Ponte-Negretti CI, Wyss FS, Piskorz D, Liprandi ÁS, Lorenzatti A, Machado L, López-Jaramillo P, Barbosa E, Gómez-Mancebo JR, López-Santi R, Valdez O, Cobos L, Puente-Barragan A, Borrayo G, Ruiz E. Ponte-Negretti CI, et al. Among authors: lorenzatti a. Glob Heart. 2021 Apr 27;16(1):27. doi: 10.5334/gh.960. Glob Heart. 2021. PMID: 34040940 Free PMC article.
Atherogenic Dyslipidemia in Latin America: Prevalence, causes and treatment: Expert's position paper made by The Latin American Academy for the Study of Lipids (ALALIP) Endorsed by the Inter-American Society of Cardiology (IASC), the South American Society of Cardiology (SSC), the Pan-American College of Endothelium (PACE), and the International Atherosclerosis Society (IAS).
Ponte-Negretti CI, Isea-Perez JE, Lorenzatti AJ, Lopez-Jaramillo P, Wyss-Q FS, Pintó X, Lanas F, Medina J, Machado-H LT, Acevedo M, Varleta P, Bryce A, Carrera C, Peñaherrera CE, Gómez-M JR, Lozada A, Merchan-V A, Piskorz D, Morales E, Paniagua M, Medina-Palomin F, Villar-M RA, Cobos L, Gómez-Alvares E, Alonso R, Colan J, Chirinos J, Lara J, Ullauri V, Arocha I. Ponte-Negretti CI, et al. Among authors: lorenzatti aj. Int J Cardiol. 2017 Sep 15;243:516-522. doi: 10.1016/j.ijcard.2017.05.059. Epub 2017 May 18. Int J Cardiol. 2017. PMID: 28552520 Review.
Attitudes and Recommendations of Physicians towards Alcohol Consumption and Cardiovascular Health: A Perspective from Argentina.
Lopez Santi R, Haseeb S, Alexander B, D Ovidio A, Gimenez S, Secotaro C, Martinez Demaria D, Pupi LM, Costantini S, Piskorz D, Amarilla A, Lorenzatti A, Gutierrez N, Hopman W, Baranchuk A. Lopez Santi R, et al. Among authors: lorenzatti a. Diseases. 2018 Sep 1;6(3):77. doi: 10.3390/diseases6030077. Diseases. 2018. PMID: 30200449 Free PMC article.
The selective peroxisome proliferator-activated receptor alpha modulator (SPPARMα) paradigm: conceptual framework and therapeutic potential : A consensus statement from the International Atherosclerosis Society (IAS) and the Residual Risk Reduction Initiative (R3i) Foundation.
Fruchart JC, Santos RD, Aguilar-Salinas C, Aikawa M, Al Rasadi K, Amarenco P, Barter PJ, Ceska R, Corsini A, Després JP, Duriez P, Eckel RH, Ezhov MV, Farnier M, Ginsberg HN, Hermans MP, Ishibashi S, Karpe F, Kodama T, Koenig W, Krempf M, Lim S, Lorenzatti AJ, McPherson R, Nuñez-Cortes JM, Nordestgaard BG, Ogawa H, Packard CJ, Plutzky J, Ponte-Negretti CI, Pradhan A, Ray KK, Reiner Ž, Ridker PM, Ruscica M, Sadikot S, Shimano H, Sritara P, Stock JK, Su TC, Susekov AV, Tartar A, Taskinen MR, Tenenbaum A, Tokgözoğlu LS, Tomlinson B, Tybjærg-Hansen A, Valensi P, Vrablík M, Wahli W, Watts GF, Yamashita S, Yokote K, Zambon A, Libby P. Fruchart JC, et al. Among authors: lorenzatti aj. Cardiovasc Diabetol. 2019 Jun 4;18(1):71. doi: 10.1186/s12933-019-0864-7. Cardiovasc Diabetol. 2019. PMID: 31164165 Free PMC article. Review.
Ambulatory Patients with Cardiometabolic Disease and Without Evidence of COVID-19 During the Pandemic. The CorCOVID LATAM Study.
Santi RL, Márquez MF, Piskorz D, Saldarriaga C, Lorenzatti A, Wyss F, Martín AV, Perales JS, Arcela JC, de Lourdes Rojas Gimon E, Sambadaro G, Perez GE, Mendoza I, Lanas F, Flores R, Liprandi AS, Alexander B, Baranchuk A. Santi RL, et al. Among authors: lorenzatti a. Glob Heart. 2021 Feb 17;16(1):15. doi: 10.5334/gh.932. Glob Heart. 2021. PMID: 33833939 Free PMC article.
Latin American Consensus on management of residual cardiometabolic risk. A consensus paper prepared by the Latin American Academy for the Study of Lipids and Cardiometabolic Risk (ALALIP) endorsed by the Inter-American Society of Cardiology (IASC), the International Atherosclerosis Society (IAS), and the Pan-American College of Endothelium (PACE).
Ponte-Negretti CI, Wyss FS, Piskorz D, Santos RD, Villar R, Lorenzatti A, López-Jaramillo P, Toth PP, Amaro AJJ, Rodrigo AK, Lanas F, Urina-Triana M, Lara J, Valdés TO, Gomez-Mancebo JR, Bryce A, Cobos S L, Puente-Barragan A, Ullauri-Solórzano VE, Medina-Palomino FA, Lozada AF, Duran M, Berrospi P, Miranda D, Badimon JJ, González JJR, Libby P. Ponte-Negretti CI, et al. Among authors: lorenzatti a. Arch Cardiol Mex. 2022 Jan 3;92(1):99-112. doi: 10.24875/ACM.21000005. Arch Cardiol Mex. 2022. PMID: 34187049 Free PMC article.
The Attitudes of Physicians Toward Guideline Recommendations for the Management of Dyslipidemia in Clinical Practice - The VIPFARMA ISCP Project.
Lopez-Santi R, Piskorz D, Garcia-Zamora S, Martinez D, Martinez-Demaria D, Renna N, Forte E, Ibarrola M, Igolnikof D, Lorenzatti A, Alexander B, Baranchuk A, Sosa-Liprandi A, Martinez F, Kaski JC. Lopez-Santi R, et al. Among authors: lorenzatti a. Curr Probl Cardiol. 2023 Jan;48(1):101434. doi: 10.1016/j.cpcardiol.2022.101434. Epub 2022 Oct 2. Curr Probl Cardiol. 2023. PMID: 36198357 Review.
Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk.
Das Pradhan A, Glynn RJ, Fruchart JC, MacFadyen JG, Zaharris ES, Everett BM, Campbell SE, Oshima R, Amarenco P, Blom DJ, Brinton EA, Eckel RH, Elam MB, Felicio JS, Ginsberg HN, Goudev A, Ishibashi S, Joseph J, Kodama T, Koenig W, Leiter LA, Lorenzatti AJ, Mankovsky B, Marx N, Nordestgaard BG, Páll D, Ray KK, Santos RD, Soran H, Susekov A, Tendera M, Yokote K, Paynter NP, Buring JE, Libby P, Ridker PM; PROMINENT Investigators. Das Pradhan A, et al. Among authors: lorenzatti aj. N Engl J Med. 2022 Nov 24;387(21):1923-1934. doi: 10.1056/NEJMoa2210645. Epub 2022 Nov 5. N Engl J Med. 2022. PMID: 36342113 Clinical Trial.
Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol.
Schwartz GG, Szarek M, Bittner VA, Diaz R, Goodman SG, Jukema JW, Landmesser U, López-Jaramillo P, Manvelian G, Pordy R, Scemama M, Sinnaeve PR, White HD, Gabriel Steg P; ODYSSEY Outcomes Committees and Investigators. Schwartz GG, et al. J Am Coll Cardiol. 2021 Aug 3;78(5):421-433. doi: 10.1016/j.jacc.2021.04.102. J Am Coll Cardiol. 2021. PMID: 34325831 Free PMC article. Clinical Trial.
51 results